- Home
- EEA vs VNRX Comparison
EEA vs VNRX Comparison
Compare EEA & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEA
- VNRX
- Stock Information
- Founded
- EEA 1986
- VNRX N/A
- Country
- EEA Germany
- VNRX United States
- Employees
- EEA N/A
- VNRX N/A
- Industry
- EEA Trusts Except Educational Religious and Charitable
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- EEA Finance
- VNRX Health Care
- Exchange
- EEA Nasdaq
- VNRX Nasdaq
- Market Cap
- EEA 73.2M
- VNRX 69.7M
- IPO Year
- EEA N/A
- VNRX N/A
- Fundamental
- Price
- EEA $10.82
- VNRX $0.43
- Analyst Decision
- EEA
- VNRX Strong Buy
- Analyst Count
- EEA 0
- VNRX 4
- Target Price
- EEA N/A
- VNRX $3.50
- AVG Volume (30 Days)
- EEA 9.2K
- VNRX 1.0M
- Earning Date
- EEA 01-01-0001
- VNRX 11-13-2025
- Dividend Yield
- EEA 1.92%
- VNRX N/A
- EPS Growth
- EEA N/A
- VNRX N/A
- EPS
- EEA N/A
- VNRX N/A
- Revenue
- EEA N/A
- VNRX $1,319,252.00
- Revenue This Year
- EEA N/A
- VNRX $324.32
- Revenue Next Year
- EEA N/A
- VNRX $247.82
- P/E Ratio
- EEA N/A
- VNRX N/A
- Revenue Growth
- EEA N/A
- VNRX 35.10
- 52 Week Low
- EEA $7.45
- VNRX $0.40
- 52 Week High
- EEA $9.26
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- EEA 47.75
- VNRX 32.82
- Support Level
- EEA $10.67
- VNRX $0.43
- Resistance Level
- EEA $10.95
- VNRX $0.48
- Average True Range (ATR)
- EEA 0.13
- VNRX 0.04
- MACD
- EEA -0.02
- VNRX -0.00
- Stochastic Oscillator
- EEA 33.33
- VNRX 18.18
About EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.